Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms

Valerio De Stefano, Tiziano Barbui, Vincenzo Di Lazzaro et al.|Blood Cancer Journal|2018

Cited by 38